John R Jones
Brighton and Sussex Medical School(GB)University of Sussex(GB)King's College Hospital NHS Foundation Trust(GB)East Sussex Healthcare NHS Trust(GB)King's College Hospital(GB)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Cancer Treatment and Pharmacology, Histone Deacetylase Inhibitors Research, Peptidase Inhibition and Analysis
Most-Cited Works
- → Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma(2015)560 cited
- → Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial(2018)337 cited
- → APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma(2015)312 cited
- → Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients(2017)233 cited
- → Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?(2015)143 cited
- → Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control(2017)104 cited